fda compounded semaglutide enforcement news Compounded' weight-loss drugs are a growing problem for state regulators • NC Newsline Judge Upholds FDA Deadline Ending

When you eat less food, youre more likely to experience nutrient gaps

Medication access through Willow reflects several conditions that are disclosed only at a high level: A completed online intake is required before any medication discussion occurs

AI: still waiting for liftoff Last years edition of the Deloitte report was titled Be brave, be bold and urged pharma companies to embrace AI-powered drug development platforms, automation and advanced analytics as a path to reversing decades of declining R&D productivity

In Eli Lillys Phase 3 TRIUMPH-1 trial, the 12 mg group lost an average of 28.3% body weight over 80 weeks, with 45.3% achieving at least 30% weight loss